Explore the vast range of titles available.

Omniphobic membranes, due to their exceptional properties, have drawn significant attention for overcoming the bottleneck in membrane distillation (MD) technology. This study demonstrates an innovative method for fabricating an omniphobic membrane that is simple and facile compared to other methods such as wet/dry etching and photolithography. The surface morphology of springtails was imitated using electrospraying technique to coat a polyvinylidene fluoride substrate with concave-shaped polystyrene beads that were successfully developed by controlling the electrical traction (voltage) and air resistance (humidity). Then, the lipid coating of springtail surfaces was mimicked by dip-coating the membrane in a low-toxicity short-chain perfluoropolyether lubricant. The concave structure’s tiny air pockets increased membrane hydrophobicity significantly, indicated by the fact that the first round of water bouncing took only 16.3 ms. Finally, in MD treatment of seawater containing 1.0 mM sodium dodecyl sulfate, the optimized omniphobic membrane maintained a stable 99.9% salt rejection rate. Here, authors successfully fabricated a springtail-inspired nano-concave reentrant structured polystyrene (PS) membrane using electrospraying technology followed by lubricant dip-coating, which endowed the membrane with omniphobic properties.

Empirical correlations for mass transfer coefficient and friction factor are often used in process models for reverse osmosis (RO) membrane systems. These usually involve four dimensionless groups, namely Reynolds number (Re), Sherwood number (Sh), friction factor (f), and Schmidt number (Sc), with the associated coefficients and exponents being obtained by fitting to experimental data. However, the range of geometric and operating conditions covered by the experiments is often limited. In this study, new dimensionless correlations for concentration polarization (CP) modulus and friction factor are presented, which are obtained by dimensional analysis and using simulation data from computational fluid dynamics (CFD). Two-dimensional CFD simulations are performed on three configurations of spacer-filled channels with 76 combinations of operating and geometric conditions for each configuration, covering a broad range of conditions encountered in RO membrane systems. Results obtained with the new correlations are compared with those from existing correlations in the literature. There is good consistency in the predicted CP with mean discrepancies less than 6%, but larger discrepancies for pressure gradient are found among the various friction factor correlations. Furthermore, the new correlations are implemented in a process model with six spiral wound modules in series and the predicted recovery, pressure drop, and specific energy consumption are compared with a reference case obtained by ROSA (Reverse Osmosis System Analysis, The Dow Chemical Company). Differences in predicted recovery and pressure drop are up to 5% and 83%, respectively, highlighting the need for careful selection of correlations when using predictive models in process design. Compared to existing mass transfer correlations, a distinct advantage of our correlations for CP modulus is that they can be directly used to estimate the impact of permeate flux on CP at a membrane surface without having to resort to the film theory.

Alteplase is the only FDA-approved drug for thrombolysis in acute ischemic stroke (AIS). Meanwhile, several thrombolytic drugs are deemed to be promising candidates to substitute alteplase. This paper evaluates the efficacy and safety of urokinase, ateplase, tenecteplase, and reteplase for intravenous AIS therapy by computational simulations of the pharmacokinetics and pharmacodynamics combined with a local fibrinolysis model. The performances of the drugs are evaluated by comparing clot lysis time, plasminogen activator inhibitor (PAI) inhibition resistance, intracranial hemorrhage (ICH) risk, and activation time from drug administration to clot lysis. Our results reveal that urokinase has the quickest lysis completion but the highest ICH risk due to excess fibrinogen depletion in systemic plasma. While tenecteplase and alteplase have very similar thrombolysis efficacy, tenecteplase has a lower risk of ICH and better resistance to PAI-1. Among the four simulated drugs, reteplase has the slowest fibrinolysis rate, but fibrinogen concentration in systemic plasma is unaffected during thrombolysis.

False lumen thrombosis (FLT) in type B aortic dissection has been associated with the progression of dissection and treatment outcome. Existing computational models mostly assume rigid wall behavior which ignores the effect of flap motion on flow and thrombus formation within the FL. In this study, we have combined a fully coupled fluid–structure interaction (FSI) approach with a shear-driven thrombosis model described by a series of convection–diffusion reaction equations. The integrated FSI-thrombosis model has been applied to an idealized dissection geometry to investigate the interaction between vessel wall motion and growing thrombus. Our simulation results show that wall compliance and flap motion can influence the progression of FLT. The main difference between the rigid and FSI models is the continuous development of vortices near the tears caused by drastic flap motion up to 4.45 mm. Flap-induced high shear stress and shear rates around tears help to transport activated platelets further to the neighboring region, thus speeding up thrombus formation during the accelerated phase in the FSI models. Reducing flap mobility by increasing the Young’s modulus of the flap slows down the thrombus growth. Compared to the rigid model, the predicted thrombus volume is 25% larger using the FSI-thrombosis model with a relatively mobile flap. Furthermore, our FSI-thrombosis model can capture the gradual effect of thrombus growth on the flow field, leading to flow obstruction in the FL, increased blood viscosity and reduced flap motion. This model is a step closer toward simulating realistic thrombus growth in aortic dissection, by taking into account the effect of intimal flap and vessel wall motion.

Purpose This study establishes a multiphysics simulation platform for both conventional and targeted thrombolysis using tissue plasminogen activator (tPA). Based on our computational results, the effects of therapeutic parameters on the dynamics of thrombolysis and the risk of side effects are investigated. Methods The model extends our previously developed one-dimensional(1D) mathematical models for fibrinolysis by incorporating targeted thrombolysis. It consists of two parts: (i) a coupled mathematical model of systemic pharmacokinetics (PK) and pharmacodynamics (PD) and local PD in a 1D occluded artery, and (ii) a mechanistic model for a targeted thrombolytic system via activated platelet-targeted tPA-loaded nanovesicles (tPA-NV), with model parameters derived from our in vitro experiments. A total of 16 therapeutic scenarios are simulated by varying the clot location and composition as well as the dosing regimen with free tPA or tPA-NV. Results Our simulation results indicate that tPA-NV offers several advantages over free tPA for thrombolysis. It reduces systemic exposure of tPA, thereby minimising the risk of bleeding complications. Simulations with different tPA-NV doses reveal that tPA-NV at 10% of the recommended dose can be as effective as the standard regimen with the full recommended dose of free tPA, demonstrating the potential of our tPA-NV as a new thrombolytic strategy with a reduced tPA dose. Moreover, faster recanalisation can be achieved with tPA-NV, especially for platelet-rich(or fibrin-poor) clots. Conclusions Our simulation platform for thrombolysis with well-tuned model parameters can be used to evaluate and optimise treatment regimens of existing and new thrombolytic therapies via benefit/risk assessment under various therapeutic scenarios.

Membrane scaling is a barrier to membrane distillation (MD). In this study, 3D-printed carbon nanotube (CNT) spacer was used to investigate its capability for mitigating membrane scaling during MD and to elucidate the scaling mechanism experimentally and theoretically. CNT spacer was tested under temperature-dependent calcium sulfate scaling conditions, and optical coherence tomography (OCT) and scanning electron microscopy (SEM) were used to measure scaling quantitatively. CNT spacer exhibited unique membrane scaling mechanism, where only a 37% reduction (29 Lm −2 h −1 ) in the initial flux was achieved, even above a volume concentration factor (VCF) of 4. On the other hand, the membrane with a polylactic acid (PLA) spacer (controls) entirely lost flux before reaching a VCF of 3.5. Interestingly, bubble formation was observed in CNT spacer, which could be attributed to the enhanced flux and vaporization rate on membrane surface in the presence of rough-surfaced CNT spacer. Bubbly flow along the membrane channel with CNT spacer can potentially reduce surface scaling on membrane during MD. Moreover, due to the surface roughness of CNT spacer, the initial nuclei might be detached more easily from CNT spacer surface than from smooth PLA surface and grow further into larger crystals in the bulk, resulting in reduced dissolved solutes in the solution. This phenomenon was indirectly corroborated by comparing the experimentally measured fluxes and theoretically computed values from our mechanistic model of MD-crystallization developed in this study. Therefore, this study revealed that CNT spacer with rough surfaces can potentially have benefit of mitigating membrane scaling during MD.

Membrane technology is crucial for water treatment as it effectively separates and rejects pollutants. However, its industrial application is often limited by membrane scaling and fouling issues, which degrade membrane performance and affect the efficiency and longevity of membrane systems. Our previous study demonstrated that a 3D-printed carbon nanotube (CNT) spacer improved membrane performance by increasing the membrane flux and controlling scaling in membrane distillation. Here, we present a detailed mechanism by which a CNT spacer mitigates membrane scaling by inducing cooling crystallisation. The CNT spacer delayed crystallisation and reduced crystal adhesion on both the membrane and spacer surfaces. Additionally, the presence of the CNT spacer resulted in the formation of larger crystals that are less likely to adhere to surfaces. The nanoscale roughness and nanochannels created by the exposed CNT in the spacer appeared to strengthen hydrogen bonding within the solution, further delaying crystallisation and reducing crystal adhesion. These findings were corroborated by comparing the experimental observations with theoretical predictions derived from our mechanistic model, providing a comprehensive understanding of the scaling mitigation process. Our approach addresses several limitations of membrane technology, enhancing performance and reducing scaling and fouling risks, paving the way for broader application in water treatment.

Background: Combined intravenous thrombolysis and mechanical thrombectomy (IVT-MT) is a common treatment in acute ischaemic stroke, however the interaction between IVT and MT from a physiological standpoint is poorly understood. In this pilot study, we conduct numerical simulations of combined IVT-MT with various idealised stent retriever configurations to evaluate performance in terms of complete recanalisation times and lysis patterns. Methods: A 3D patient-specific geometry of a terminal internal carotid artery with anterior and middle cerebral arteries is reconstructed, and a thrombus is artificially implanted in the MCA branch. Various idealised stent retriever configurations are implemented by varying stent diameter and stent placement, and a configuration without a stent retriever provides a baseline for comparison. A previously validated multi-level model of thrombolysis is used, which incorporates blood flow, drug transport, and fibrinolytic reactions within a fibrin thrombus. Results: Fastest total recanalisation was achieved in the thrombus without a stent retriever, with lysis times increasing with stent retriever diameter. Two mechanisms of clot lysis were established: axial and radial permeation. Axial permeation from the clot front was the primary mechanism of lysis in all configurations, as it facilitated increased protein binding with fibrin fibres. Introducing a stent retriever channel allowed for radial permeation, which occurred at the fluid-thrombus interface, although lysis was much slower in the radial direction because of weaker secondary velocities. Conclusions: Numerical models can be used to better understand the complex physiological relationship between IVT and MT. Two different mechanisms of lysis were established, providing a basis towards improving the efficacy of combined treatments.

The purpose of this study is to establish a practical simulation model based on mass balance, mass transport equations and equilibrium equation between gas and liquid phases across a porous membrane in membrane contactor process in order to predict the separation behavior by the gassing process of gas mixture in membrane contactor. The established simulation model was verified by comparison between the simulated values and real process values in the separation of CH4/CO2 mixture, showing an excellent agreement between them. The parameter R-value in the model, which is a kind of the permeability of permeant across porous membrane, has been determined by fitting a numerical solution of the model equation to the experimental data to obtain a practical value of the parameter. A parametric study on the gassing process of N2/CO2 mixture in membrane contactor was made with the help of the practical simulation model to investigate the effects of operation parameters on separation performance and to characterize the separation behavior of membrane contactor process. A series of simulations of the separation of N2/CO2 mixture in membrane contactor were conducted, and the optimization on the membrane process was discussed to maximize the separation performance in terms of N2 recovery percent in retentate and CO2 permeation rate. It was observed from the analysis of the result of the simulation that liquid flow rate has a negative effect on N2 recovery percent in retentate but a positive effect on the separation of CO2, while R-value affects the separation performance in the other way. It is confirmed in this study that the developed simulation can be used as a tool to optimize the parameters, i.e., feed gas pressure, liquid flow rate and R-value to maximize the separation performance.

Thrombolytic therapy is one of the medical procedures in the treatment of acute ischaemic stroke (AIS), whereby the tissue plasminogen activator (tPA) is intravenously administered to dissolve the obstructive blood clot. The treatment of AIS by thrombolysis can sometimes be ineffective and it can cause serious complications, such as intracranial haemorrhage (ICH). In this study, we propose an efficient mathematical modelling approach that can be used to evaluate the therapeutic efficacy and safety of thrombolysis in various clinically relevant scenarios. Our model combines the pharmacokinetics and pharmacodynamics of tPA with local clot lysis dynamics. By varying the drug dose, bolus-infusion delay time, and bolus-infusion ratio, with the FDA approved dosing protocol serving as a reference, we have used the model to simulate 13 dose regimens. Simulation results are compared for temporal concentrations of fibrinolytic proteins in plasma and the time that is taken to achieve recanalisation. Our results show that high infusion rates can cause the rapid degradation of plasma fibrinogen, indicative of increased risk for ICH, but they do not necessarily lead to fast recanalisation. In addition, a bolus-infusion delay results in an immediate drop in plasma tPA concentration, which prolongs the time to achieve recanalisation. Therefore, an optimal administration regimen should be sought by keeping the tPA level sufficiently high throughout the treatment and maximising the lysis rate while also limiting the degradation of fibrinogen in systemic plasma. This can be achieved through model-based optimisation in the future.